Researchers performed a double-blind randomized study to investigate the efficacy of tDCS as an augmentation strategy to sertraline in the treatment of vascular depression.
There are concerns exist that the use of selective serotonin reuptake inhibitors increases the risk of developing type 2 diabetes in adults, but the evidence for children and adolescents is limited.
Researchers conducted a retrospective study to assess self-injury behavior in patients with bipolar disorder and comorbid ADHD after initiation of a central stimulant.
Investigators examined the mRNA signature foundation associated with the pro-inflammatory phenotype of depression, along with the differential signatures linked to depression subtypes and the impact of antidepressant agents.
About half of waivered clinicians prescribe buprenorphine for opioid use disorder and most treat at levels below their patient limits.
The 10-item progress assessment tool represents a pragmatic approach to ongoing monitoring in substance use disorders.
Cannabidiol (CBD) may be a safe and effective treatment option for cannabis use disorder.
The use of genetic evaluation for suicidal ideation may represent a future application for precision medicine.
A meta-analysis of randomized, controlled trials compared the use of benzodiazepines alone or in combination with antipsychotic or antihistamine medications in patients experiencing acute psychotic illness.
Transcranial direct current stimulation may be an effective add-on treatment for bipolar depression.
